One day after the head of a pharmaceutical lobbying group called out Martin Shkreli’s price-hiking controversy in a TV interview, the notorious “pharma bro” and recent Twitter exile is striking back. With a new website called “Pharma Skeletons,” Shkreli has begun cataloging instances of similar price hikes throughout the broader industry. The website opens with a message to Stephen Ubl, chief executive of the lobbying group PhRMA: “Don’t you dare point your finger at me for the pharmaceutical industry’s troubles. It turns out we’ve all made some unpopular moves.”
collectionsInnovation FestivalCurrent Issue
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system.
The major tech ecosystems that battle for our attention and dollars.
What’s next for hardware, software, and services.
The brave new world of automation, from AI to drones.
How our urban centers are building toward the future.
Most Creative People
See members of our Most Creative People in Business community: leaders who are shaping the future of business in creative ways.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company's distinctive lens.